Kinzler, M.N.; Klasen, C.; Schulze, F.; Herrmann, E.; Schnitzbauer, A.A.; Trojan, J.; Zeuzem, S.; Wild, P.J.; Walter, D.
Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based Chemotherapy. J. Clin. Med. 2022, 11, 2057.
https://doi.org/10.3390/jcm11072057
AMA Style
Kinzler MN, Klasen C, Schulze F, Herrmann E, Schnitzbauer AA, Trojan J, Zeuzem S, Wild PJ, Walter D.
Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based Chemotherapy. Journal of Clinical Medicine. 2022; 11(7):2057.
https://doi.org/10.3390/jcm11072057
Chicago/Turabian Style
Kinzler, Maximilian N., Christina Klasen, Falko Schulze, Eva Herrmann, Andreas A. Schnitzbauer, Jörg Trojan, Stefan Zeuzem, Peter J. Wild, and Dirk Walter.
2022. "Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based Chemotherapy" Journal of Clinical Medicine 11, no. 7: 2057.
https://doi.org/10.3390/jcm11072057
APA Style
Kinzler, M. N., Klasen, C., Schulze, F., Herrmann, E., Schnitzbauer, A. A., Trojan, J., Zeuzem, S., Wild, P. J., & Walter, D.
(2022). Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based Chemotherapy. Journal of Clinical Medicine, 11(7), 2057.
https://doi.org/10.3390/jcm11072057